“When cancer’s in your life, Canteen is in your corner with whatever support you need. Dealing with cancer can be pretty overwhelming so it’s great to work with partners like MedAdvisor to make living with cancer that little bit easier,” said Canteen CEO Peter Orchard.
“MedAdvisor is a market leading program in terms of empowering patients and driving medication adherence and we are excited to offer this as a key pillar of our service offer to pharmacy.” – Dennis Bastas, Chairman and Group CEO of Arrotex Pharmaceuticals.
“As a business that is passionately committed to helping people live longer, healthier, happier lives, we are thrilled to partner with MedAdvisor to help tackle this challenge. We believe that MedAdvisor is a fantastic example of how simple technological solutions can empower people to improve their health outcomes through better managing their medications,” – Bupa Medical Director, Shared Services, Dr Tim Ross.
“Diabetes Australia’s mission is to minimise the impact of diabetes. We can do this by supporting self-management and innovative services. We believe that the MedAdvisor platform offers a great solution that will empower people with diabetes to better manage their health.” - Adjunct Professor Greg Johnson, CEO of Diabetes Australia.
“We are excited to be partnering with MedAdvisor to help our community improve their health outcomes through medication adherence. Medications are a significant factor in the treatment of epilepsy and we believe MedAdvisor can deliver benefits to people living with epilepsy in the management of their medications.” – Carol Ireland, CEO and Managing Director of Epilepsy Action Australia.
“For people living with epilepsy, life can be challenging. MedAdvisor can support people to manage their medications and we’re looking forward to working together in a collaborative context to improve health outcomes for people living with epilepsy” – Graeme Shears, CEO of Epilepsy Foundation.
“We are excited about working closely with MedAdvisor. We believe the MedAdvisor app is an important innovation that will help patients and their carers to make a measurable difference to health outcomes for people with epilepsy. The app will facilitate some tailored information which will help bring epilepsy out of the shadows, and we look forward to promoting it to our community.” - Helen Whitehead, CEO of Epilepsy Queensland.
“We know that effective glaucoma treatment has the power to save sight. Eye drops are the most common form of treatment for glaucoma, but approximately 50% of patients don’t take their drops as prescribed, increasing the amount of vision loss caused by glaucoma. MedAdvisor is a wonderful app that assists people to actively manage their glaucoma treatment regime more effectively.” – Annie Gibbins, CEO of Glaucoma Australia.
Assess Your Risk
Glaucoma Australia has developed this risk calculator to help you assess your potential risk of developing glaucoma based on age, gender, ethnicity, family history of glaucoma and other health issues such as diabetes and myopia. Calculate your risk of developing glaucoma, and find out what to do about it.
Early detection and adherence to treatment are vital to slow glaucoma progression. Read more here.
“This partnership provides us with the ability to tap into a significantly sized patient group and to make a real difference in the way they manage their medication. With the costs associated with Osteoporosis rising, MedAdvisor also has the opportunity to play a role in keeping these costs down by improving medication adherence and education. We are delighted to be partnering with Osteoporosis Australia to achieve these important goals,” – Robert Read, CEO of MedAdvisor.
“The availability of smartphones and devices means that we can empower patients to manage their own health and MedAdvisor is ideally placed to play an active role in helping patients to better manage their medications.” – Lesley Brydon, CEO of Painaustralia.
“We are thrilled to be partnering with MedAdvisor to help our community improve their health outcomes through medication adherence. Medication timing is a crucial part of living with Parkinson’s and we encourage clients to take them ‘on time, every time’. The MedAdvisor platform is world class and can deliver significant benefits to people living with Parkinson’s in the management of their medication, and it is for this reason we partnered with them.” – Steve Sant, CEO of Parkinson’s Australia..
“The Stroke Foundation partners with the community to prevent, treat and beat stroke. Ongoing management of stroke risk factors, such as blood pressure, is essential for many stroke survivors. Medication has a key role in reducing stroke risk and MedAdvisor will help make taking and managing these treatments easier.” – Sharon McGowan, Chief Executive of Stroke Foundation.